Rheumatology and Immunology
风湿免疫科 · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Established in 2017, this department treats rheumatic diseases affecting joints, bones, muscles, blood vessels, and connective tissues. It manages over 200 conditions, including systemic lupus erythematosus, rheumatoid arthritis, ankylosing spondylitis, and vasculitis. The team uses immune testing, genetic analysis, and biopsies of the kidney, lip glands, lymph nodes, or skin to improve early diagnosis and create personalized treatment plans. Facilities include an outpatient clinic, inpatient ward with more than 50 beds, a laboratory, and a biologic infusion center. The department emphasizes chronic disease management through electronic patient records and regular patient support groups.
Conditions and treatments
- Diagnosis and treatment of systemic lupus erythematosus and rheumatoid arthritis
- Management of ankylosing spondylitis and psoriatic arthritis
- Treatment of dermatomyositis, scleroderma, and Sjogren's syndrome
- Care for vasculitis and Behcet's disease
- Immune status testing and genetic analysis
- Biologic agent infusion services
Key facts
- The department was established in 2017.
- The inpatient ward has more than 50 beds.
- Over 200 types of rheumatic diseases are recognized.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Rheumatology and Immunology |
|---|---|
| Doctors listed | 10 |
| Chief physicians | 1 |
Senior doctors
Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).
Chief physicians
- Xueyi Li李学义 · Professor
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us